Neurology Update: Epilepsy
Get a glimpse of the key highlights, insights, and standout moments from EAN 2025 in Helsinki, all captured in our Congress Review eBook.
Latest Posts
-
-
EAN NewsResearch
Publication „Side effects of cancer therapies“ (Vol 1 and Vol 2) Released
March 19, 2021The book on complications of cancer therapy has been edited by 4 experienced editors; Cavaletti G, Grisold W, Oberndorfer St and Soffietti R and contains 35 chapters written by international experts in the field. -
Executive Page from Professor Bassetti
-
Research HighlightsResearch
Neurology Update: Coordinating Panel on Rare Neurological Diseases
March 12, 2021Neurology Update: Coordinating Panel on Rare Neurological Diseases -
Neurology Update: Rare Diseases
-
Jes Olensen, clinical professor in the department of clinical neurology, Rigshospitalet, Denmark, has been awarded the Brain Prize along with Michael Moskowitz, Lars Edvinsson and Peter Goadsby for discovering a key mechanism that causes migraine which has since led to revolutionary new treatments.
-
Other News
European Research Area Network Coordinating National and Regional Funding for the Future and Emerging Technologies Flagships (FLAG-ERA) Calls
March 4, 2021FLAG-ERA gathers National and Regional Funding Organisations (NRFOs) in Europe and beyond with the goal of supporting, together with the European Commission, the FET Flagship initiatives, i.e., the Graphene Flagship and the Human Brain Project (HBP) Flagship. -
InterviewsEAN NewsCOVID-19
COVID-19 around the World: Clinician interviews on experience and impact of the virus (Cape Verde)
March 3, 2021COVID-19 around the World: Clinician interviews on experience and impact of the virus (Cape Verde) -
News from EAN member societiesOther News
News from EMA: First oral treatment for spinal muscular atrophy (SMA) recommended for approval
March 3, 2021News from EMA: First oral treatment for spinal muscular atrophy (SMA) recommended for approval -
EAN NewsResearchOther News
Brain Talks: Professor Günther Deuschl addresses burden of neurological diseases in Europe
March 3, 2021Brain Talks: Professor Günther Deuschl addresses burden of neurological diseases in Europe -
Breaking newsCOVID-19Research
Serum and CSF alpha-synuclein levels do not change in COVID-19 patients with neurological symptoms
March 3, 2021Serum and CSF alpha-synuclein levels do not change in COVID-19 patients with neurological symptoms -
Breaking newsCOVID-19Research
COVID-19 continuous-EEG case series: A Descriptive Study
March 3, 2021COVID-19 continuous-EEG case series: A Descriptive Study -
Breaking newsCOVID-19Research
Acute ischemic stroke and COVID-19: An analysis of 27 676 Patients
March 3, 2021Acute ischemic stroke and COVID-19: An analysis of 27 676 Patients -
Breaking newsCOVID-19Research
Inflammatory cytokine patterns associated with neurological diseases in COVID-19
March 3, 2021Inflammatory cytokine patterns associated with neurological diseases in COVID-19 -
Breaking newsCOVID-19Research
Susceptibility of neuroblastoma and glioblastoma cell lines to SARS-CoV-2 infection
March 3, 2021Susceptibility of neuroblastoma and glioblastoma cell lines to SARS-CoV-2 infection